{"name":"Cady, Roger, M.D.","slug":"cady-roger-m-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dextromethorphan and quinidine","genericName":"Dextromethorphan and quinidine","slug":"dextromethorphan-and-quinidine","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"naratriptan HCl","genericName":"naratriptan HCl","slug":"naratriptan-hcl","indication":"Acute treatment of migraine with or without aura in adults","status":"marketed"}]}],"pipeline":[{"name":"Dextromethorphan and quinidine","genericName":"Dextromethorphan and quinidine","slug":"dextromethorphan-and-quinidine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"naratriptan HCl","genericName":"naratriptan HCl","slug":"naratriptan-hcl","phase":"marketed","mechanism":"Naratriptan selectively binds to serotonin 5-HT1B/1D receptors on cranial blood vessels and nerve terminals to constrict blood vessels and inhibit neuropeptide release, thereby relieving migraine headaches.","indications":["Acute treatment of migraine with or without aura in adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE1VQ0dWSFZzYXRsZWVfblV1T05sbWU3V2tBZzhLT243NlUyLWYzdUZYcW5LS2oyM19GcURlQkkxTjJsY2hkSW93VVFTWTQ5YmZVdHpCMUlnWVRkRTQ?oc=5","date":"2026-02-27","type":"pipeline","source":"The Pharma Letter","summary":"Slate Medicines - The Pharma Letter","headline":"Slate Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQaE1vUk5uZXBxRS1LWExkOTJ4ZDRCTnBnZGN1SmhBZ2xRQ21ET1M3TEF3QjNWTVJrQXlMRTlfU1JrZjlxTmtJdllBM3NZUFByNTI5VWJGU1drRWpXUXUzTnNLd0JsTGVQam1kVm9mdUlqUUxCcVNZMldHSWpnS2E0eS03clZSUm01Yy1aSlhpd1JLOWN6dXpUbENFanUtNXd6by1OWlFDNjEtNlNsS3JxSG1zdUFnNlBiNmFlekIzUHZxXy1ZQW9OUWhMckN6bThNNmJQR3JrQkZDTjZtcEhySmZjZ3VNZk1nVktBZzFuU2czQjNwaFgweThhb3J2Sy1VN3E3VDFrakxaQmxac09GamNsWjh3LUV6MVNYSA?oc=5","date":"2026-02-24","type":"pipeline","source":"BioSpace","summary":"Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders - BioSpace","headline":"Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNTjQ5QkVUQURJVFJJX2RfeGRuaHRGWDJwZ3RYdV9Cc1VIbHVVVXZyaDY5OXVRUFVBSThycHQ1ZmRTSjk0aWloNmIxaEE2S2FOMEdIckFObmhGUGtRZld1d1ZadHJQdV96U1FvbXZfSVp5SDdfSkt6SGlOY2luY0VjUnFqNUdXRkUyMVlQR0huejgxZTBvUlJ6N1BkSEdwYjNXS0I3UWNoWlVSdkk?oc=5","date":"2026-02-24","type":"pipeline","source":"Fierce Biotech","summary":"Slate aims to solve migraine injection equation with $130M, asset from Chinese biotech - Fierce Biotech","headline":"Slate aims to solve migraine injection equation with $130M, asset from Chinese biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9PU25EbmNaSFBkSGdCbVJXU0xOemRiWWxSaWxTM0RKckQ3Q3J0enVvdUxZSk1VSmpaTDR5NWlIdTNHZmpCbkc0WmdJSWVOaEpNWXVLWFRmaEZDbmxIdFZIRE1fU3BBV0HSAWxBVV95cUxQM1VqaU9EZHA3ODNLbFZMdi1xTnVkM2VBaDU1R2tnNTJUV0dWWlBXS1U2VHcwYXM1dlRSdlZQcEoxcUlON3hiUXZSWHd1enBMQVp0S0o1SVVIV1BFTVJZQjUxTUZnY3lVMzN1MFE?oc=5","date":"2026-02-24","type":"pipeline","source":"Pulse 2.0","summary":"Slate Medicines: $130 Million Series A Raised To Advance Anti-PACAP Migraine Therapies - Pulse 2.0","headline":"Slate Medicines: $130 Million Series A Raised To Advance Anti-PACAP Migraine Therapies - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPZ3NVcnpGUHVzT2x3amJZYllQOXBmUFF6c0F0djRRZDZUTGlGYTJnY290dlNMYTNLVERnRklUa09Ya0xNQXdpd3VUUVdyVXNZeXZfNzNvU1Q5RGpFeFFySHhxbGJLTjRwVHBfMGFPU0dCVGtJX2tFMmhJTHk0ZVNTeFRHb2t5X21QLVN0Z0RGbjhaU2NYUDJrYmx0eXkwcUU0aXRjZ3hrbFdQaUpIZnNIWlpB?oc=5","date":"2020-02-24","type":"regulatory","source":"Healio","summary":"FDA approves Vyepti, first IV preventive treatment for migraine - Healio","headline":"FDA approves Vyepti, first IV preventive treatment for migraine","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQaHRhNzN1TzVrQmZtSHh6Y2E5cm5oYnRXaEl5Q2xEeGRPWDR0ZkQtczUyZWpfWnY0MzdJeXBrd0FTY1R1SHVGRGZKS3ZDa1hDMmRIQ0E3ZkptM1VXWFN3NzZEcV9nYmlScVdPUWNGVE1ISmt2cFptUFI5NENYdGV6aXh3LTFSQ01FaWdQcnp2ekNtWG1DTnkteXE0Mzl1Zw?oc=5","date":"2016-01-28","type":"regulatory","source":"MultiVu","summary":"Avanir Pharmaceuticals Announces FDA Approval of ONZETRA - MultiVu","headline":"Avanir Pharmaceuticals Announces FDA Approval of ONZETRA","sentiment":"positive"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}